Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study

PURPOSE: Treatment targeting immune checkpoint with programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors has demonstrated efficacy and tolerability in the treatment of metastatic urothelial carcinoma (mUC). We investigated the efficacy and safety of atezolizumab in mUC patients who...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Res Treat
Main Authors: Hur, Joon Young, Kim, Youjin, Kwon, Ghee-Young, Kang, Minyong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Lee, Su Jin, Park, Se Hoon
Format: Artigo
Sprog:Inglês
Udgivet: Korean Cancer Association 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790849/
https://ncbi.nlm.nih.gov/pubmed/30653744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.604
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker